<DOC>
	<DOCNO>NCT02700659</DOCNO>
	<brief_summary>The aim trial determine performance characteristic Cxbladder test detection recurrent urothelial carcinoma ( UC ) patient recent history urinary tract UC , treat accord standard practice undergo routine investigative cystoscopy . The gold standard determination clinical truth cystoscopy , plus follow investigation relate current visit .</brief_summary>
	<brief_title>The Cxbladder Monitoring Study</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<criteria>Confirmed positive diagnosis primary recurrent urinary tract UC past 2 year . Patient undergo investigative cystoscopies monitor recurrence UC interval prescribe clinical practitioner Patient 18 year age older . Prior genitourinary manipulation ( cystoscopy / catheterisation / dilation ) 14 day urine collection , current urinary tract infection , current know history urinary tract inflammatory disorder , recent history glomerulonephritis , nephrosis renal inflammatory disorder , recent history pyelonephritis Patient undergone total bladder cystectomy treatment bladder UC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>